The nurse’s role in the care of the cardiotoxicities generated by chemotherapy administration




Nurse’s Role; Anticarcinogenic Agents; Cardiotoxicity; Antineoplasic Agents; Nursing Care; Teaching.


Cardiac toxicity is severe and an adverse effect of many chemotherapy drugs. The following guiding research question used was: how does the nurse provide health care for prevention and treatment of chemotherapy induced cardiotoxicity? This study is an Integrative Literature Review of which articles were searched in the Scielo, PubMed and BVS databases. The inclusion criteria were complete texts in Portuguese, English, and Spanish, published within a five-year period and indexed with the used keywords. The exclusion criteria were incomplete texts published over five years. The research indicates that there is a need of increasing the literary productions on the theme as well as a need of creating specific tools and guidelines to help nurses and the health care team to coordinate the care of cancer patients with cardiotoxicities generated by chemotherapeutic agents. It was also revealed that the nurse, as the only member of the health team that assists the patient in its entirety and in a holistic manner, has a crucial role in the management of risk factors, being able to act in the detection of the appearance of new signs and symptoms in the patients' routine, as well as guidance to eliminate or minimize their damage.


Austin-Mattison C. (2018). Joining Forces: Establishing a Cardio-oncology Clinic. Journal of the advanced practitioner in oncology, 9(2), 222–229.

Bonassa, E. M. A.; & Gato, M. I. R. (2012). Terapêutica oncológica para enfermeiros e farmacêuticos. Atheneu.

Brunner & Suddarth. (2020) Tratado de Enfermagem Médico-cirúrgica. Janice L. Hinkle, Kerry H. Cheever. (14a ed.), Guanabara Koogan.

COFEN (1998) Resolução 210.

Correction to: Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. (2019). Circulation, 140(9), e543.

Coviello, J. S (2018). Cardiovascular and Cancer Risk: The Role of Cardio-oncology. Journal of the advanced prater in oncology, 9 (2), 160-176.

Curigliano et al. (2012) Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines†, Annals of Oncology, 2(7) 155-166,

Curigliano, G., Fradley, M., Ganatra, S., Barac, A., Blaes. A., Herrmann, J., & Jordan, K., on behalf of the ESMO Guidelines Committee. (2020). Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Annals of Oncology, 31(2), 171-190

Clark, R. A., Marin, T. S., Berry, N. M. et al. Avaliação de cardiotoxicidade e risco de doença cardiovascular em pacientes recebendo tratamento para câncer de mama. Cardio-Oncology 3, 6 (2017).

Clark, R. A, Marin, T S, McCarthy, A. L., et al. Cardiotoxicidade após o tratamento do câncer: um mapa do processo da jornada de tratamento do paciente. Cardio-Oncology 5, 14 (2019).

Fadol A. P. (2018). Management of Chemotherapy-Induced Left Ventricular Dysfunction and Heart Failure in Patients With Cancer While Undergoing Cancer Treatment: The MD Anderson Practice. Frontiers in cardiovascular medicine, 5, 24.

Susan C. G. et al. (2019) Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American heart association. Circulation. 2019;139:e997–e1012.

Grossman, S. C.; Porth, C. M. (2019). Fisiopatologia. Guanabara Koogan.

Guyton, A. C. & Hall J. E. (2017). Tratado de Fisiologia Médica. Elsevier. (13a ed.).

Hajjar et al., (2020). Diretriz Brasileira de Cardio-oncologia – 2020. Arquivos Brasileiros de Cardiologia, 115(5), 1006-1043.

Higgins, A. Y et al., (2021). Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. PloS one, 16(2), e0246764.

Hoff PMG et al. (2013). Tratado de Oncologia. Atheneu.

Kelly, F., Carroll, S. L., Carley, M., Dent, S., Shorr, R., Hu, J., Morash, R., & Stacey, D. (2017). Symptom practice guide for telephone assessment of patients with cancer treatment-related cardiotoxic dyspnea: Adaptation and evaluation of acceptability. Cardio-oncology (London, England), 3, 7.

Kumar, V.; Abbas, A. K.; & Aster. (2013). J.C. Patologia Básica. (9a ed.), Elsevier.

Melo, Marcelo Dantas Tavares de, & Salemi, Vera Maria Cury. (2019). Utilidade dos Índices de Deformação Miocárdica na Prevenção da Cardiotoxicidade em Pacientes com Câncer de Mama. Arquivos Brasileiros de Cardiologia, 112(1), 57-58.

Ministério da Saúde. INCA. (2019). Estimativa 2020: incidência de câncer no Brasil.

Netter, F. H. (2018). Atlas de Anatomia Humana. (7a ed.), Artmed.

Potter, P. A.; & Perry, A. G. (2013). Fundamentos de Enfermagem. Elsevier.

Rodrigues, Andrea Bezerra; Martin, Leila Gonçalves Rocha; Moraes, Márcia Wanderley de. (2016). Oncologia multiprofissional: bases para assistência. Série manuais de especialização Einstein. Manole.

Silva, J. M., da et al., (2018). Cardiovascular adverse events associated with oral antineoplastic therapy. Revista Brasileira de Enfermagem, 71(5), 2561-2569.

OMS. (2020). WHO report on cancer: setting priorities, investing wisely and providing care for all.

OMS. (2020). The top 10 causes of death.



How to Cite

TEIXEIRA, T. M.; LORDEIRO, N. P. F. .; SILVA, R. C. da; GODINHO, L. The nurse’s role in the care of the cardiotoxicities generated by chemotherapy administration. Research, Society and Development, [S. l.], v. 11, n. 7, p. e15111729732, 2022. DOI: 10.33448/rsd-v11i7.29732. Disponível em: Acesso em: 7 jul. 2022.



Health Sciences